<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">5307925</article-id>
    <article-id pub-id-type="publisher-id">1540</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-017-1540-0</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>VacSol: a high throughput <italic>in silico</italic> pipeline to predict potential therapeutic targets in prokaryotic pathogens using subtractive reverse vaccinology</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Rizwan</surname>
          <given-names>Muhammad</given-names>
        </name>
        <address>
          <email>razi_sadiqpk@hotmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Naz</surname>
          <given-names>Anam</given-names>
        </name>
        <address>
          <email>anam.naz88@live.com</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Ahmad</surname>
          <given-names>Jamil</given-names>
        </name>
        <address>
          <email>dr.ahmad.jamil@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Naz</surname>
          <given-names>Kanwal</given-names>
        </name>
        <address>
          <email>kanwal.naz03@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Obaid</surname>
          <given-names>Ayesha</given-names>
        </name>
        <address>
          <email>ayesha_obaid_nust@live.com</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Parveen</surname>
          <given-names>Tamsila</given-names>
        </name>
        <address>
          <email>tamsilap@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ahsan</surname>
          <given-names>Muhammad</given-names>
        </name>
        <address>
          <email>ahsan.chattha15@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Ali</surname>
          <given-names>Amjad</given-names>
        </name>
        <address>
          <email>amjaduni@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2234 2376</institution-id><institution-id institution-id-type="GRID">grid.412117.0</institution-id><institution>Research Center for Modelling and Simulation (RCMS), </institution><institution>National University of Sciences and Technology (NUST), </institution></institution-wrap>H-12, Islamabad, Pakistan </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2234 2376</institution-id><institution-id institution-id-type="GRID">grid.412117.0</institution-id><institution>Atta-ur-Rahman School of Applied Biosciences (ASAB), </institution><institution>National University of Sciences and Technology (NUST), </institution></institution-wrap>H-12, Islamabad, Pakistan </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9284 9490</institution-id><institution-id institution-id-type="GRID">grid.418920.6</institution-id><institution>Biosciences Department, </institution><institution>COMSATS Institute of Information Technology, </institution></institution-wrap>Islamabad, Pakistan </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>13</day>
      <month>2</month>
      <year>2017</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>13</day>
      <month>2</month>
      <year>2017</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2017</year>
    </pub-date>
    <volume>18</volume>
    <elocation-id>106</elocation-id>
    <history>
      <date date-type="received">
        <day>27</day>
        <month>9</month>
        <year>2016</year>
      </date>
      <date date-type="accepted">
        <day>8</day>
        <month>2</month>
        <year>2017</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s). 2017</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p>With advances in reverse vaccinology approaches, a progressive improvement has been observed in the prediction of putative vaccine candidates. Reverse vaccinology has changed the way of discovery and provides a mean to propose target identification in reduced time and labour. In this regard, high throughput genomic sequencing technologies and supporting bioinformatics tools have greatly facilitated the prompt analysis of pathogens, where various predicted candidates have been found effective against certain infections and diseases. A pipeline, VacSol, is designed here based on a similar approach to predict putative vaccine candidates both rapidly and efficiently.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p>VacSol, a new pipeline introduced here, is a highly scalable, multi-mode, and configurable software designed to automate the high throughput <italic>in silico</italic> vaccine candidate prediction process for the identification of putative vaccine candidates against the proteome of bacterial pathogens. Vaccine candidates are screened using integrated, well-known and robust algorithms/tools for proteome analysis, and the results from the VacSol software are presented in five different formats by taking proteome sequence as input in FASTA file format. The utility of VacSol is tested and compared with published data and using the <italic>Helicobacter pylori</italic> 26695 reference strain as a benchmark.</p>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p>VacSol rapidly and efficiently screens the whole bacterial pathogen proteome to identify a few predicted putative vaccine candidate proteins. This pipeline has the potential to save computational costs and time by efficiently reducing false positive candidate hits. VacSol results do not depend on any universal set of rules and may vary based on the provided input. It is freely available to download from: <ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/vacsol/">https://sourceforge.net/projects/vacsol/</ext-link>.</p>
      </sec>
      <sec>
        <title>Electronic supplementary material</title>
        <p>The online version of this article (doi:10.1186/s12859-017-1540-0) contains supplementary material, which is available to authorized users.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Reverse vaccinology</kwd>
      <kwd>Computational pipeline</kwd>
      <kwd>Vaccine candidates</kwd>
      <kwd>Subtractive proteomics</kwd>
      <kwd>PVCs</kwd>
      <kwd>VacSol</kwd>
    </kwd-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2017</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p><italic>In silico</italic> prediction of vaccine candidates has great significance in various life science disciplines, including biomedical research [<xref ref-type="bibr" rid="CR1">1</xref>]. The conventional approach of vaccine development requires pathogenic cultivation in vitro that is not always possible. Although this methodology has the potential to produce successful vaccines and has long been in practice, but now considered time-consuming and inadequate for most pathogens. This caveat is particularly evident when microbes are inactive, protective, or even in the case where antigen expression is decreased; rendering the conventional approach a significant challenge for putative vaccine candidate discovery [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. These basic problems have led scientists to develop new vaccinology approaches based on advanced computational tools. In particular, with the introduction of high-throughput sequencing techniques over the last decade and the advent of bioinformatics approaches, Rino Rappouli revolutionized Pasteur’s vaccinology procedure by introducing a novel “reverse vaccinology” method [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR6">6</xref>]. This advanced <italic>in-silico</italic> technique for vaccine prediction couples genomic information and analysis with bioinformatics tools. Using this approach, several vaccines have been successfully developed against microbial pathogens [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR9">9</xref>]. Reverse vaccinology is now recognized as safer and more reliable as compared to conventional vaccinology methods [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p>
    <p>Using the reverse vaccinology approach, various predictive and analytical tools (Vaxign, VaxiJen, JennerPredict) have been designed for the identification of putative vaccine candidates. These tools are widely available online [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR14">14</xref>], but only a handful of softwares and pipelines, like NERVE and Vacceed [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], are accessible as full packages. Although web-based pipelines are efficient, their drawbacks include time delays and constraints for input file size.</p>
    <p>NERVE (New Enhanced Reverse Vaccinology Environment), a Perl based modular pipeline for <italic>in-silico</italic> identification of potential vaccine candidates, generates results through text interface configuration and is an efficient, modular-based standalone software for vaccine candidate identification [<xref ref-type="bibr" rid="CR15">15</xref>]. But it only focuses on adhesion proteins whereas several non-adhesion proteins can also participate in host-pathogen interactions (including porin, flagellin, invasin, etc.), and most of them are pathogenic as well as antigenic. Therefore, there exists a perilous need for an updated and advanced analysis tool that inclusively provides every putative candidate in its output.</p>
    <p>Vacceed is another highly configurable architecture designed to perform high throughput <italic>in silico</italic> identification of eukaryotic vaccine candidates. Vacceed is, in fact, able to reduce false vaccine candidates that are selected for laboratory validation to save time and money [<xref ref-type="bibr" rid="CR16">16</xref>], but this highly efficient, scalable, and configurable program provides limited information on pathogenicity and putative functional genes. These main parameters prove instrumental in the determination of potential vaccine candidates. Thus, given the current software limitations, we sought to utilize the reverse vaccinology approach to overcome limitations of currently available pipelines.</p>
    <p>We therefore focused on <italic>in silico</italic> reverse vaccinology approach to address the issues that were present in previous pipelines, and to precisely screen out the putative vaccine candidates from whole bacterial genome <italic>in silico</italic>. We designed a new automated pipeline, termed VacSol, to efficiently screen for the therapeutic vaccine agents from the bacterial pathogen proteome to save both time and resources.</p>
  </sec>
  <sec id="Sec2">
    <title>Implementation</title>
    <p>VacSol was designed to screen and detect prioritized proteins as vaccine candidates, and its functionality is presented in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. Notably, this software was developed on platform independent Java language, is highly flexible through one executable .jar file, and does not require any software installation. The VacSol functionality does depend on the installation of various tools that are used as pre-requisites for the pipeline execution (such as PSORTb for localization prediction), and we have integrated various freely available, well-performing and updated tools in the VacSol pipeline to achieve optimal performance. VacSol has been tested and analyzed to be fully functional on Ubuntu 12.04.5 (64 bit) version. It can also work on any operating system with already installed and functional prerequisite tools, given minor modifications. PSORTb [<xref ref-type="bibr" rid="CR17">17</xref>] and OSDDlinux (<ext-link ext-link-type="uri" xlink:href="http://osddlinux.osdd.net/">http://osddlinux.osdd.net/</ext-link>) have also been pre-packaged for robust and user-friendly installation (See installation guide).<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic diagram of the protein prioritization process. Steps to prioritize proteins to identify PVCs include: (1) the complete bacterial proteome (sequences) subjected to the VacSol pipeline for identifying PVCs; (2) the complete proteome is searched for non-host homologous, essential, virulent proteins residing in the extracellular membrane with less than two transmembrane helices; (3) proteins that meet the selection criteria are considered to be PVC proteins; (4) prioritized proteins are further analyzed for antigenic B- and T-cell epitopes</p></caption><graphic xlink:href="12859_2017_1540_Fig1_HTML" id="MO1"/></fig>
</p>
    <p>VacSol also offers the user to select either a single tool (selective) or complete pipeline to predict potential vaccine candidates (PVCs). Protein sequences are subjected to the main analytical process where the input format is validated through the FASTA Validator for vaccine target prediction. This main process is multi-threaded, as one can run as many threads as there are cores available in their system. Further, the pipeline is capable of processing multiple sequences in parallel. The process of sequence prioritization is performed in a number of steps to prioritize the input sequences, and is elaborated in Fig. <xref rid="Fig2" ref-type="fig">2</xref>. Each step is forwarded by a special script and protein sequences are screened at every step indistinctly with generated results displayed in various formats. After processing all the sequences of an input file, the prioritized sequences are then subjected for epitope mapping. Thereafter, all prioritized sequences are again directed to thread pool processing to generate final results. Final results are engendered in five different formats (FASTA, XML, JSon, HTML, and PDF format), ensuring the expandability and scalability of the designed pipeline for users. Step-wise information of VacSol is provided in a comprehensive user guide (Additional file <xref rid="MOESM1" ref-type="media">1</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Schematic diagram of VacSol processing. VacSol is comprised of two working modes: (i) GUI, and (ii) Standalone. The software is highly flexible as it permits users to submit a FASTA proteome sequence in four different ways. Submitted input is validated through a FASTA validator, and then VacSol screens the whole proteome to prioritize proteins that have antigenic B- and T-cell epitopes. Individual tool results (Localizer, Blaster, Helicer, and Epitoper) and complete results are generated for prioritized proteins in five different formats</p></caption><graphic xlink:href="12859_2017_1540_Fig2_HTML" id="MO2"/></fig>
</p>
    <sec id="Sec3">
      <title>Distinct features</title>
      <p>The VacSol interface is designed on four different modules: (i) Blaster, a module for predicting homology using BLASTp; (ii) Localization Predictor, predicting subcellular location; (iii) Helicer, predicting transmembrane helices; and, (iv) Epitoper, a module designed to predict B-cell and T-cell epitopes. These modules function on the basis of implemented tools (Table <xref rid="Tab1" ref-type="table">1</xref>) required to screen prioritized proteins (targets). The VacSol pipeline is developed in Java, a platform independent language [<xref ref-type="bibr" rid="CR18">18</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Tools and databases integrated and implemented in VacSol</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Name</th><th>Function</th><th>Source(S)</th></tr></thead><tbody><tr><td>BLAST+2.2.25-7</td><td>New command line sequence alignment application developed using the NCBI C++ toolkit.</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td>Pftools2.3</td><td>Package of programs that support the search method of generalized profile formatting.</td><td>[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td>PSORTb3.0</td><td>Protein subcellular localization prediction tool.</td><td>[<xref ref-type="bibr" rid="CR17">17</xref>]</td></tr><tr><td>HMMTOP 2.0</td><td>Transmembrane topology prediction tool.</td><td>[<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td>DEG 10.0</td><td>Database of essential genes.</td><td>[<xref ref-type="bibr" rid="CR28">28</xref>]</td></tr><tr><td>VFDB</td><td>Virulence factors database.</td><td>[<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td>ABCPred</td><td>B-Cell epitope prediction tool.</td><td>[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td>Propred-I</td><td>Prediction of promiscuous major histocompatibility complex (MHC) Class-I binding sites.</td><td>[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td>Propred</td><td>Prediction of MHC Class-II binding regions in an antigen sequence.</td><td>[<xref ref-type="bibr" rid="CR42">42</xref>]</td></tr><tr><td>UniProt-SwissProt</td><td>Manually annotated protein sequences database with information extracted from literature.</td><td>[<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]</td></tr></tbody></table></table-wrap>
</p>
    </sec>
  </sec>
  <sec id="Sec4" sec-type="results">
    <title>Results</title>
    <sec id="Sec5">
      <title>Test data</title>
      <p>VacSol performs various proteome-wide analyses and generates results in five different formats. This pipeline was validated using a sample data set of the <italic>Helicobacter pylori</italic> proteome. The selected strain of <italic>H. pylori</italic> 26695 (RefSeq NC_000915.1) is comprised of 1576 proteins or coding regions [<xref ref-type="bibr" rid="CR19">19</xref>], and the whole proteome was scanned in each protein prioritizing step.</p>
    </sec>
    <sec id="Sec6">
      <title>Implementation of VacSol for test data</title>
      <p>The first working step was performed by identifying the non-host homologs, required to elute host homologous proteins to restrict the chance of autoimmunity [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Out of 1576 possible proteins, 1452 were screened as non-human homologous proteins by using BLASTp against RefSeq [<xref ref-type="bibr" rid="CR22">22</xref>] and SwissProt [<xref ref-type="bibr" rid="CR23">23</xref>] databases. For BLAST non-human homologs, criteria included a Bit Score &gt;100, E-Value &lt;1.0 e<sup>(−5)</sup>, and percentage identity &gt;35% [<xref ref-type="bibr" rid="CR24">24</xref>]. Next, these 1452 proteins were subjected for further protein prioritization processing by VacSol to predict subcellular localization. 65 proteins were found to be in the secretome and exoproteome, of which 23 proteins lie in the extracellular region, and 42 were screened as outer-membrane proteins. Prioritization of proteins according to localization substantially contributed to enhance the PVCs identification process [<xref ref-type="bibr" rid="CR25">25</xref>]. Surface exposed proteins tend to be involved in pathogenesis, making them prime targets as vaccine candidates [<xref ref-type="bibr" rid="CR26">26</xref>]. Similarly, both extracellular and secreted proteins are readily accessible to antibodies as compared to intracellular proteins, and therefore represent ideal vaccine candidates. Results obtained through PSORTb, and integrated in VacSol, were then cross-checked with CELLO2GO [<xref ref-type="bibr" rid="CR27">27</xref>] to confirm the localization of putative candidate proteins. After localization validation, screened proteins were checked for their essentiality. 667 proteins were sorted as essential genes required for the survival of gastric pathogen <italic>H. pylori</italic>. Finally, 10 proteins have been prioritized following all the criteria. This analysis reduced the cost and time of PVCs identification by excluding proteins with no suitable features for further processing.</p>
      <p>The Database of Essential Genes (DEG) [<xref ref-type="bibr" rid="CR28">28</xref>] was then used to predict essential genes. Results demonstrated that all 10 of the prioritized proteins were essential proteins, thus making them putative vaccine candidates. In the next step, the proteome was screened for virulent proteins, as identification of virulent factors in essential proteins is a key step in the vaccine development process [<xref ref-type="bibr" rid="CR29">29</xref>]. Essential genes of a pathogen tend to be virulent, substantiating these checks as key factors in the prediction of target proteins to prioritize vaccine candidates [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. In our case, 267 proteins were found to be virulent proteins among whole proteome of the pathogen.</p>
      <p>VFDB [<xref ref-type="bibr" rid="CR31">31</xref>] results, coinciding with our pipeline-generated results, demonstrated that all prioritized proteins contained virulence factors, concluding that these 10 proteins are potential vaccine targets. Next, proteins were checked for their transmembrane topology. VacSol explored 1254 proteins with less than 2 transmembrane helices, as these proteins are often deemed the best candidates. Having more than one transmembrane helix in a protein makes expression and colonization difficult, and multiple transmembrane helices fail to purify recombinant proteins for vaccine development [<xref ref-type="bibr" rid="CR21">21</xref>]. HMMTOP version 2.0 [<xref ref-type="bibr" rid="CR32">32</xref>] was applied to enumerate transmembrane helices with default parameter values. Subsequently, proteins were checked for their functional annotation from UniProt (Table <xref rid="Tab2" ref-type="table">2</xref>) [<xref ref-type="bibr" rid="CR33">33</xref>]. UniProt characterizes functionality of proteins based on sequence and/or similarity with functionally annotated proteins [<xref ref-type="bibr" rid="CR23">23</xref>]. Insight into the role of targeted proteins in a system provides a detailed understanding as to how putative targets can be used to reduce pathogen burden and virulence. Prioritized proteins included 3 homologs of <italic>FecA</italic> (HP1400, HP0807, HP0686), <italic>FlaA</italic> (HP0601), <italic>FlaB</italic> (HP0115), <italic>HcpA</italic> (HP0211), <italic>HcpC</italic> (HP1098), and toxin-like outer membrane proteins (HP0289, HP0610, and HP0922). B-cell and T-cell epitopes screened for prioritized candidates along with their features (location, score, no. of MHC I &amp; II binding alleles) have been shown in results file (Additional file <xref rid="MOESM2" ref-type="media">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Functional annotation of prioritized proteins</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Protein ID (VacSol)</th><th>Bacterial protein</th><th>Gene symbol (NCBI)</th><th>Molecular weight kDa (ExPASy)</th><th>Molecular function (UNIPROT)</th><th>Domains (Interpro Scan)</th><th>Trans-membrane Helices</th></tr></thead><tbody><tr><td>3</td><td>Iron(III) dicitrate transport protein (FecA)</td><td>HP1400</td><td char="." align="char">94.827</td><td>Receptor activity</td><td>TonB-dependent receptor &amp; plug domain</td><td>0</td></tr><tr><td>285</td><td>Flagellin A (FlaA)</td><td>HP0601</td><td char="." align="char">53.287</td><td>Cell motility, Signal transduction and structural molecule activity</td><td>Flagellin, Flagellin_D0/D1, Flagellin_hook_IN_motif</td><td>0</td></tr><tr><td>534</td><td>Putative beta-lactamase</td><td>HP1098</td><td char="." align="char">31.594</td><td>Beta-lactamase activity</td><td>Sel1-like, TPRlike_ helical_dom, TPR_2</td><td>0</td></tr><tr><td>825</td><td>Iron(III) dicitrate transport protein (FecA)</td><td>HP0807</td><td char="." align="char">88.946</td><td>Receptor activity</td><td>TonB-dependent receptor &amp; plug domain</td><td>0</td></tr><tr><td>837</td><td>Flagellin B (FlaB)</td><td>HP0115</td><td char="." align="char">53.882</td><td>Structural molecule activity</td><td>Flagellin, Flagellin_D0/D1</td><td>0</td></tr><tr><td>907</td><td>Toxin-like outer membrane protein</td><td>HP0289</td><td char="." align="char">311.288</td><td>Not defined</td><td>Autotransport_beta&amp; Vacuolating_cytot oxin_put</td><td>1</td></tr><tr><td>995</td><td>Toxin-like outer membrane protein</td><td>HP0922</td><td char="." align="char">274.563</td><td>Not defined</td><td>VacA2 (motif), Autotransporte_beta, PbH1</td><td>0</td></tr><tr><td>982</td><td>Beta-lactamase HcpA</td><td>HP0211</td><td char="." align="char">27.366</td><td>Peptidoglycan, cell wall synthesis</td><td>Sel1-like, TPRlike_helical_dom</td><td>0</td></tr><tr><td>1184</td><td>Toxin-like outer membrane protein</td><td>HP0610</td><td char="." align="char">212.964</td><td>Not defined</td><td>Vacuolating cytotoxin putative &amp; Autotransporter beta domain</td><td>0</td></tr><tr><td>1359</td><td>Iron(III) dicitrate transport protein (FecA)</td><td>HP0686</td><td char="." align="char">87.698</td><td>Receptor activity</td><td>TonB-dependent receptor, betabarrel, plug domain</td><td>0</td></tr></tbody></table></table-wrap>
</p>
      <p>An overview of the results displayed by VacSol are shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>. Each protein sequence was assigned a unique VacSol ID for retrieval, and the overall results for <italic>H. pylori</italic> are provided as Additional file <xref rid="MOESM2" ref-type="media">2</xref>. The total duration of these analyses was 90 min, on a machine with 2GB RAM.<fig id="Fig3"><label>Fig. 3</label><caption><p>VacSol-generated results. VacSol generated a summary report for the complete <italic>H. pylori</italic> proteome with prioritized proteins. Each protein is assigned a unique VacSol ID</p></caption><graphic xlink:href="12859_2017_1540_Fig3_HTML" id="MO3"/></fig>
</p>
    </sec>
  </sec>
  <sec id="Sec7" sec-type="discussion">
    <title>Discussion</title>
    <p>The prioritized putative vaccine targets against <italic>H. pylori</italic> 26695 included <italic>FecA</italic> (HP1400), <italic>FecA</italic> (HP0807), <italic>FecA</italic> (HP0686), <italic>FlaA</italic> (HP0601), <italic>FlaB</italic> (HP0115), <italic>HcpA</italic> (HP0211), <italic>HcpC</italic> (HP1098), and toxin-like outer membrane proteins (HP0289, HP0610, and HP0922). Among these target candidates, Iron (III) dicitrate transport protein, <italic>FecA</italic> (HP1400, HP0807, and HP0686), interacts with <italic>TonB</italic>, a protein involved in the virulence process. Previous studies have shown that controlled and mutated <italic>TonB</italic> leads to increased immunization [<xref ref-type="bibr" rid="CR34">34</xref>]. Indeed, by targeting HP1400, HP0807, and HP0686, <italic>TonB</italic> can be controlled, making these three promising putative vaccine candidates.</p>
    <p>Flagelline proteins (<italic>flaA</italic> and <italic>flaB</italic>) are responsible for the pro-inflammation of gastric mucosa that leads to the development of gastric/peptic ulcers, making <italic>flaA</italic> and <italic>flaB</italic> considerable candidates for novel vaccine development [<xref ref-type="bibr" rid="CR35">35</xref>]. Likewise, Beta-lactamase <italic>HcpA</italic> and <italic>HcpC</italic> are highly pathogenic proteins that are directly involved in different infections caused by <italic>H. pylori</italic> [<xref ref-type="bibr" rid="CR36">36</xref>]. The <italic>HcpA</italic> protein is also involved in bacterial and eukaryotic host interaction [<xref ref-type="bibr" rid="CR37">37</xref>]. These protein annotations verify that VacSol limited its screening to the proteins that are biologically relevant putative and therapeutic vaccine candidates.</p>
    <p>Previous studies have linked three toxin-like proteins with virulent proteins and vaccine candidates <italic>BabA</italic>, <italic>CagS</italic>, <italic>Cag6, HpaA</italic>, and <italic>VacA</italic> [<xref ref-type="bibr" rid="CR21">21</xref>]. Indeed, <italic>Cag</italic> proteins are also well-known pathogenic proteins, involved in pathogenic pathways, while the <italic>HcpA</italic> protein has been shown to be involved in bacterial and eukaryotic host interactions [<xref ref-type="bibr" rid="CR37">37</xref>]. Using our computational approach, we have designed the VacSol pipeline to further the field of vaccinology by reducing time, cost and trial burdens in novel putative vaccine candidate protein identification. Proteins predicted using this pipeline against <italic>H. pylori</italic> strain may serve as promising PVCs against gastric pathogens, as substantiated by previous findings in the literature. Further evaluation of these PVCs can lead to the development of novel and effective vaccines against <italic>H. pylori</italic>.</p>
  </sec>
  <sec id="Sec8" sec-type="conclusion">
    <title>Conclusion</title>
    <p>VacSol is a new, highly efficient, and user-friendly pipeline established for biological scientists, including those with limited expertise in computational analyses. VacSol has restricted the pool of promising PVCs from the whole bacterial pathogen proteome by automatizing the <italic>in silico</italic> reverse vaccinology approach for the prediction of highly antigenic targeted proteins, via a user controlled step-wise process. This new pipeline is an efficient tool in the contexts of time and computational/experimental costs by eliminating false positive candidates from laboratory evaluation. The modular structure of VacSol improves the prediction process of vaccine candidates with additional potential for future development in this field.</p>
  </sec>
  <sec id="Sec9">
    <title>Availability and requirements</title>
    <p><bold>Project name:</bold> VacSol: An <italic>in silico</italic> pipeline to predict potential therapeutic targets</p>
    <p>
      <bold>Project home page:</bold>
      <ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/vacsol/files/">https://sourceforge.net/projects/vacsol/files/</ext-link>
    </p>
    <p><bold>Archived version:</bold> Not available</p>
    <p><bold>Operating system(s):</bold> Linux</p>
    <p><bold>Programming language:</bold> Java</p>
    <p><bold>Other requirements</bold> (Pre Requisite Tools/Languages):</p>
    <p>• PSORTb [<xref ref-type="bibr" rid="CR17">17</xref>]</p>
    <p>• NCBI BLAST+ [<xref ref-type="bibr" rid="CR38">38</xref>]</p>
    <p>• Pftools [<xref ref-type="bibr" rid="CR39">39</xref>]</p>
    <p>• Hmmtop [<xref ref-type="bibr" rid="CR32">32</xref>]</p>
    <p>• ABCPred [<xref ref-type="bibr" rid="CR40">40</xref>]</p>
    <p>• ProPred-I [<xref ref-type="bibr" rid="CR41">41</xref>]</p>
    <p>• ProPred [<xref ref-type="bibr" rid="CR42">42</xref>]</p>
    <p>• Java</p>
    <p>• Perl</p>
    <p>• Bioperl</p>
  </sec>
</body>
<back>
  <app-group>
    <app id="App1">
      <sec id="Sec10">
        <title>Additional files</title>
        <p>
          <media position="anchor" xlink:href="12859_2017_1540_MOESM1_ESM.pdf" id="MOESM1">
            <label>Additional file 1:</label>
            <caption>
              <p>Installation Guide. Description: Detailed user guide for installation and usage of VacSol. (PDF 1178 kb)</p>
            </caption>
          </media>
          <media position="anchor" xlink:href="12859_2017_1540_MOESM2_ESM.pdf" id="MOESM2">
            <label>Additional file 2:</label>
            <caption>
              <p>Test data results. Description: Detailed results of test data (<italic>H. pylori</italic>) generated by VacSol. (PDF 41330 kb)</p>
            </caption>
          </media>
        </p>
      </sec>
    </app>
  </app-group>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>DEG</term>
        <def>
          <p>Database of Essential Genes</p>
        </def>
      </def-item>
      <def-item>
        <term>FecA</term>
        <def>
          <p>Iron (III) dicitrate transport protein A</p>
        </def>
      </def-item>
      <def-item>
        <term>FlaA</term>
        <def>
          <p>Flagelline protein A</p>
        </def>
      </def-item>
      <def-item>
        <term>FlaB</term>
        <def>
          <p>Flagelline protein B</p>
        </def>
      </def-item>
      <def-item>
        <term>
          <italic>H. pylori</italic>
        </term>
        <def>
          <p>
            <italic>Helicobacter pylori</italic>
          </p>
        </def>
      </def-item>
      <def-item>
        <term>HcpA</term>
        <def>
          <p>Helicobacter cysteine-rich protein A</p>
        </def>
      </def-item>
      <def-item>
        <term>HcpC</term>
        <def>
          <p>Helicobacter cysteine-rich protein C</p>
        </def>
      </def-item>
      <def-item>
        <term>PVCs</term>
        <def>
          <p>Potential vaccine candidates</p>
        </def>
      </def-item>
      <def-item>
        <term>VFDB</term>
        <def>
          <p>Virulence factor database</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <ack>
    <p>We acknowledge Andreana N. Holowatyj (Ph.D) from Department of Biological Sciences, Wayne State University School of Medicine, USA for proofreading the manuscript.</p>
    <p>• Any restrictions to use by non-academics: No</p>
    <sec id="FPar1">
      <title>Funding</title>
      <p>No funding was provided for this project.</p>
    </sec>
    <sec id="FPar2">
      <title>Availability of data and materials</title>
      <p>VacSol is tested on Ubuntu and can be freely downloaded from:</p>
      <p><ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/vacsol/">https://sourceforge.net/projects/vacsol/</ext-link>.</p>
      <p>The VacSol Installation and User Guide can be obtained from:</p>
      <p><ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/vacsol/files/Installation">https://sourceforge.net/projects/vacsol/files/Installation</ext-link> and User Guide.docx/download/</p>
      <p><italic>H. pylori</italic> 26695 dataset used for analysis:</p>
      <p>Protein sequences and their locations:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="https://drive.google.com/open?id=0B4QOadCkpLvxYXNRbUd3MDF3RHM">https://drive.google.com/open?id=0B4QOadCkpLvxYXNRbUd3MDF3RHM</ext-link>
      </p>
      <p><italic>H. pylori</italic> 26695 full genome:</p>
      <p>Full genome was retrieved from NCBI RefSeq with reference number NC_000915.1, available at following link.</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000915.1">https://www.ncbi.nlm.nih.gov/nuccore/NC_000915.1</ext-link>
      </p>
    </sec>
    <sec id="FPar3">
      <title>Authors’ contributions</title>
      <p>AA conceived the idea. MR, JA, AN and AA designed the pipeline. MR implemented the software. AN and MR contributed to software validation. AN and MR composed the manuscript. JA, KN, AO, TP, and MA contributed to analyses and results, as well as in the drafting of the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
    <sec id="FPar4">
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec id="FPar5">
      <title>Consent for publication</title>
      <p>Not applicable.</p>
    </sec>
    <sec id="FPar6">
      <title>Ethics approval and consent to participate</title>
      <p>Not applicable.</p>
    </sec>
  </ack>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tarca</surname>
            <given-names>AL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Machine learning and its applications to biology</article-title>
        <source>PLoS Comput Biol</source>
        <year>2007</year>
        <volume>3</volume>
        <issue>6</issue>
        <fpage>e116</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.0030116</pub-id>
        <?supplied-pmid 17604446?>
        <pub-id pub-id-type="pmid">17604446</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Capecchi</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The genome revolution in vaccine research</article-title>
        <source>Curr Issues Mol Biol</source>
        <year>2004</year>
        <volume>6</volume>
        <fpage>17</fpage>
        <lpage>28</lpage>
        <?supplied-pmid 14632256?>
        <pub-id pub-id-type="pmid">14632256</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kimman</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Risks connected with the use of conventional and genetically engineerd vaccines</article-title>
        <source>Vet Q</source>
        <year>1992</year>
        <volume>14</volume>
        <issue>3</issue>
        <fpage>110</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="doi">10.1080/01652176.1992.9694344</pub-id>
        <?supplied-pmid 1413441?>
        <pub-id pub-id-type="pmid">1413441</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rinaudo</surname>
            <given-names>CD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Vaccinology in the genome era</article-title>
        <source>J Clin Invest</source>
        <year>2009</year>
        <volume>119</volume>
        <issue>9</issue>
        <fpage>2515</fpage>
        <lpage>25</lpage>
        <pub-id pub-id-type="doi">10.1172/JCI38330</pub-id>
        <?supplied-pmid 19729849?>
        <pub-id pub-id-type="pmid">19729849</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pizza</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing</article-title>
        <source>Science</source>
        <year>2000</year>
        <volume>287</volume>
        <issue>5459</issue>
        <fpage>1816</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1126/science.287.5459.1816</pub-id>
        <?supplied-pmid 10710308?>
        <pub-id pub-id-type="pmid">10710308</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rappuoli</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Reverse vaccinology, a genome-based approach to vaccine development</article-title>
        <source>Vaccine</source>
        <year>2001</year>
        <volume>19</volume>
        <issue>17</issue>
        <fpage>2688</fpage>
        <lpage>91</lpage>
        <pub-id pub-id-type="doi">10.1016/S0264-410X(00)00554-5</pub-id>
        <?supplied-pmid 11257410?>
        <pub-id pub-id-type="pmid">11257410</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ariel</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening</article-title>
        <source>Infect Immun</source>
        <year>2002</year>
        <volume>70</volume>
        <issue>12</issue>
        <fpage>6817</fpage>
        <lpage>27</lpage>
        <pub-id pub-id-type="doi">10.1128/IAI.70.12.6817-6827.2002</pub-id>
        <?supplied-pmid 12438358?>
        <pub-id pub-id-type="pmid">12438358</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Montigiani</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genomic approach for analysis of surface proteins in Chlamydia pneumoniae</article-title>
        <source>Infect Immun</source>
        <year>2002</year>
        <volume>70</volume>
        <issue>1</issue>
        <fpage>368</fpage>
        <lpage>79</lpage>
        <pub-id pub-id-type="doi">10.1128/IAI.70.1.368-379.2002</pub-id>
        <?supplied-pmid 11748203?>
        <pub-id pub-id-type="pmid">11748203</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ross</surname>
            <given-names>BC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis</article-title>
        <source>Vaccine</source>
        <year>2001</year>
        <volume>19</volume>
        <issue>30</issue>
        <fpage>4135</fpage>
        <lpage>42</lpage>
        <pub-id pub-id-type="doi">10.1016/S0264-410X(01)00173-6</pub-id>
        <?supplied-pmid 11457538?>
        <pub-id pub-id-type="pmid">11457538</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rappuoli</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Reverse vaccinology</article-title>
        <source>Curr Opin Microbiol</source>
        <year>2000</year>
        <volume>3</volume>
        <issue>5</issue>
        <fpage>445</fpage>
        <lpage>50</lpage>
        <pub-id pub-id-type="doi">10.1016/S1369-5274(00)00119-3</pub-id>
        <?supplied-pmid 11050440?>
        <pub-id pub-id-type="pmid">11050440</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hassan</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets</article-title>
        <source>BMC Genomics</source>
        <year>2016</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>732</fpage>
        <pub-id pub-id-type="doi">10.1186/s12864-016-2951-4</pub-id>
        <?supplied-pmid 27634541?>
        <pub-id pub-id-type="pmid">27634541</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xiang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Mobley</surname>
            <given-names>HL</given-names>
          </name>
        </person-group>
        <article-title>Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development</article-title>
        <source>Biomed Res Int</source>
        <year>2010</year>
        <volume>2010</volume>
        <fpage>29750</fpage>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Doytchinova</surname>
            <given-names>IA</given-names>
          </name>
          <name>
            <surname>Flower</surname>
            <given-names>DR</given-names>
          </name>
        </person-group>
        <article-title>VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines</article-title>
        <source>BMC Bioinformatics</source>
        <year>2007</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>4</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-8-4</pub-id>
        <?supplied-pmid 17207271?>
        <pub-id pub-id-type="pmid">17207271</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jaiswal</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Jenner-predict server: prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions</article-title>
        <source>BMC Bioinformatics</source>
        <year>2013</year>
        <volume>14</volume>
        <issue>1</issue>
        <fpage>211</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-14-211</pub-id>
        <?supplied-pmid 23815072?>
        <pub-id pub-id-type="pmid">23815072</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vivona</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bernante</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Filippini</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>NERVE: new enhanced reverse vaccinology environment</article-title>
        <source>BMC Biotechnol</source>
        <year>2006</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>35</fpage>
        <pub-id pub-id-type="doi">10.1186/1472-6750-6-35</pub-id>
        <?supplied-pmid 16848907?>
        <pub-id pub-id-type="pmid">16848907</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goodswen</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Kennedy</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Ellis</surname>
            <given-names>JT</given-names>
          </name>
        </person-group>
        <article-title>Vacceed: a high-throughput in silico vaccine candidate discovery pipeline for eukaryotic pathogens based on reverse vaccinology</article-title>
        <source>Bioinformatics</source>
        <year>2014</year>
        <volume>30</volume>
        <fpage>2381</fpage>
        <lpage>3</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btu300</pub-id>
        <?supplied-pmid 24790156?>
        <pub-id pub-id-type="pmid">24790156</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gardy</surname>
            <given-names>JL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>PSORTb v. 2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis</article-title>
        <source>Bioinformatics</source>
        <year>2005</year>
        <volume>21</volume>
        <issue>5</issue>
        <fpage>617</fpage>
        <lpage>23</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bti057</pub-id>
        <?supplied-pmid 15501914?>
        <pub-id pub-id-type="pmid">15501914</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Petty</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Sylvester</surname>
            <given-names>SA</given-names>
          </name>
        </person-group>
        <source>Specification language for defining user interface panels that are platform-independent</source>
        <year>2002</year>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Baltrus</surname>
            <given-names>DA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The complete genome sequence of Helicobacter pylori strain G27</article-title>
        <source>J Bacteriol</source>
        <year>2009</year>
        <volume>191</volume>
        <issue>1</issue>
        <fpage>447</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="doi">10.1128/JB.01416-08</pub-id>
        <?supplied-pmid 18952803?>
        <pub-id pub-id-type="pmid">18952803</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kotb</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Infection and autoimmunity: a story of the host, the pathogen, and the copathogen</article-title>
        <source>Clin Immunol Immunopathol</source>
        <year>1995</year>
        <volume>74</volume>
        <issue>1</issue>
        <fpage>10</fpage>
        <lpage>22</lpage>
        <pub-id pub-id-type="doi">10.1006/clin.1995.1003</pub-id>
        <?supplied-pmid 7994918?>
        <pub-id pub-id-type="pmid">7994918</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Naz</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Identification of putative vaccine candidates against Helicobacter pylori exploiting exoproteome and secretome: a reverse vaccinology based approach</article-title>
        <source>Infect Genet Evol</source>
        <year>2015</year>
        <volume>32</volume>
        <fpage>280</fpage>
        <lpage>91</lpage>
        <pub-id pub-id-type="doi">10.1016/j.meegid.2015.03.027</pub-id>
        <?supplied-pmid 25818402?>
        <pub-id pub-id-type="pmid">25818402</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pruitt</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Tatusova</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Maglott</surname>
            <given-names>DR</given-names>
          </name>
        </person-group>
        <article-title>NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins</article-title>
        <source>Nucleic Acids Res</source>
        <year>2007</year>
        <volume>35</volume>
        <issue>suppl 1</issue>
        <fpage>D61</fpage>
        <lpage>5</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkl842</pub-id>
        <?supplied-pmid 17130148?>
        <pub-id pub-id-type="pmid">17130148</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boeckmann</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003</article-title>
        <source>Nucleic Acids Res</source>
        <year>2003</year>
        <volume>31</volume>
        <issue>1</issue>
        <fpage>365</fpage>
        <lpage>70</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkg095</pub-id>
        <?supplied-pmid 12520024?>
        <pub-id pub-id-type="pmid">12520024</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pertsemlidis</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fondon</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>John</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Having a BLAST with bioinformatics (and avoiding BLASTphemy)</article-title>
        <source>Genome Biol</source>
        <year>2001</year>
        <volume>2</volume>
        <issue>10</issue>
        <fpage>1</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="doi">10.1186/gb-2001-2-10-reviews2002</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <mixed-citation publication-type="other">Kaufmann SH, Lambert PH. The grand challenge for the future: vaccines for poverty-related diseases from bench to field. Springer Science &amp; Business Media; 2005. <ext-link ext-link-type="uri" xlink:href="http://www.springer.com/br/book/9783764371753">http://www.springer.com/br/book/9783764371753</ext-link>.</mixed-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Grandi</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Bacterial surface proteins and vaccines</article-title>
        <source>Ital J Biochem</source>
        <year>2007</year>
        <volume>56</volume>
        <issue>3</issue>
        <fpage>R</fpage>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>C-S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>CELLO2GO: a Web server for protein subCELlular LOcalization prediction with functional gene ontology annotation</article-title>
        <source>PLoS One</source>
        <year>2014</year>
        <volume>9</volume>
        <issue>6</issue>
        <fpage>e99368</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0099368</pub-id>
        <?supplied-pmid 24911789?>
        <pub-id pub-id-type="pmid">24911789</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements</article-title>
        <source>Nucleic Acids Res</source>
        <year>2013</year>
        <volume>42</volume>
        <issue>D1</issue>
        <fpage>D574</fpage>
        <lpage>D80</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkt1131</pub-id>
        <?supplied-pmid 24243843?>
        <pub-id pub-id-type="pmid">24243843</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Handman</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Leishmaniasis: current status of vaccine development</article-title>
        <source>Clin Microbiol Rev</source>
        <year>2001</year>
        <volume>14</volume>
        <issue>2</issue>
        <fpage>229</fpage>
        <lpage>43</lpage>
        <pub-id pub-id-type="doi">10.1128/CMR.14.2.229-243.2001</pub-id>
        <?supplied-pmid 11292637?>
        <pub-id pub-id-type="pmid">11292637</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Muhammad</surname>
            <given-names>SA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Prioritizing drug targets in Clostridium botulinum with a computational systems biology approach</article-title>
        <source>Genomics</source>
        <year>2014</year>
        <volume>104</volume>
        <issue>1</issue>
        <fpage>24</fpage>
        <lpage>35</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ygeno.2014.05.002</pub-id>
        <?supplied-pmid 24837790?>
        <pub-id pub-id-type="pmid">24837790</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>VFDB: a reference database for bacterial virulence factors</article-title>
        <source>Nucleic Acids Res</source>
        <year>2005</year>
        <volume>33</volume>
        <issue>suppl 1</issue>
        <fpage>D325</fpage>
        <lpage>8</lpage>
        <?supplied-pmid 15608208?>
        <pub-id pub-id-type="pmid">15608208</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tusnady</surname>
            <given-names>GE</given-names>
          </name>
          <name>
            <surname>Simon</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>The HMMTOP transmembrane topology prediction server</article-title>
        <source>Bioinformatics</source>
        <year>2001</year>
        <volume>17</volume>
        <issue>9</issue>
        <fpage>849</fpage>
        <lpage>50</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/17.9.849</pub-id>
        <?supplied-pmid 11590105?>
        <pub-id pub-id-type="pmid">11590105</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Consortium</surname>
            <given-names>U</given-names>
          </name>
        </person-group>
        <article-title>The universal protein resource (UniProt)</article-title>
        <source>Nucleic Acids Res</source>
        <year>2008</year>
        <volume>36</volume>
        <issue>suppl 1</issue>
        <fpage>D190</fpage>
        <lpage>5</lpage>
        <pub-id pub-id-type="pmid">18045787</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hsieh</surname>
            <given-names>P-F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess</article-title>
        <source>J Infect Dis</source>
        <year>2008</year>
        <volume>197</volume>
        <issue>12</issue>
        <fpage>1717</fpage>
        <lpage>27</lpage>
        <pub-id pub-id-type="doi">10.1086/588383</pub-id>
        <?supplied-pmid 18433330?>
        <pub-id pub-id-type="pmid">18433330</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Constantinescu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Constantinescu</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Could knowledge of H. pylori pathogenicity factors lead to the emergence of new methods for identifying bacteria?</article-title>
        <source>Bull Transilvania University of Brasov, Seriels VI: Medical Sciences</source>
        <year>2014</year>
        <volume>7</volume>
        <fpage>1</fpage>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mittl</surname>
            <given-names>PR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Detection of high titers of antibody against Helicobacter cysteine-rich proteins A, B, C, and E in Helicobacter pylori-infected individuals</article-title>
        <source>Clin Diagn Lab Immunol</source>
        <year>2003</year>
        <volume>10</volume>
        <issue>4</issue>
        <fpage>542</fpage>
        <lpage>5</lpage>
        <?supplied-pmid 12853383?>
        <pub-id pub-id-type="pmid">12853383</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mittl</surname>
            <given-names>PR</given-names>
          </name>
          <name>
            <surname>Schneider-Brachert</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Sel1-like repeat proteins in signal transduction</article-title>
        <source>Cell Signal</source>
        <year>2007</year>
        <volume>19</volume>
        <issue>1</issue>
        <fpage>20</fpage>
        <lpage>31</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cellsig.2006.05.034</pub-id>
        <?supplied-pmid 16870393?>
        <pub-id pub-id-type="pmid">16870393</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Camacho</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>BLAST+: architecture and applications</article-title>
        <source>BMC Bioinformatics</source>
        <year>2009</year>
        <volume>10</volume>
        <issue>1</issue>
        <fpage>421</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-10-421</pub-id>
        <?supplied-pmid 20003500?>
        <pub-id pub-id-type="pmid">20003500</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sigrist</surname>
            <given-names>CJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>PROSITE: a documented database using patterns and profiles as motif descriptors</article-title>
        <source>Brief Bioinform</source>
        <year>2002</year>
        <volume>3</volume>
        <issue>3</issue>
        <fpage>265</fpage>
        <lpage>74</lpage>
        <pub-id pub-id-type="doi">10.1093/bib/3.3.265</pub-id>
        <?supplied-pmid 12230035?>
        <pub-id pub-id-type="pmid">12230035</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Saha</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Prediction of continuous B‐cell epitopes in an antigen using recurrent neural network</article-title>
        <source>Proteins</source>
        <year>2006</year>
        <volume>65</volume>
        <issue>1</issue>
        <fpage>40</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="doi">10.1002/prot.21078</pub-id>
        <?supplied-pmid 16894596?>
        <pub-id pub-id-type="pmid">16894596</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Singh</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>ProPred1: prediction of promiscuous MHC Class-I binding sites</article-title>
        <source>Bioinformatics</source>
        <year>2003</year>
        <volume>19</volume>
        <issue>8</issue>
        <fpage>1009</fpage>
        <lpage>14</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btg108</pub-id>
        <?supplied-pmid 12761064?>
        <pub-id pub-id-type="pmid">12761064</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Singh</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>ProPred: prediction of HLA-DR binding sites</article-title>
        <source>Bioinformatics</source>
        <year>2001</year>
        <volume>17</volume>
        <issue>12</issue>
        <fpage>1236</fpage>
        <lpage>7</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/17.12.1236</pub-id>
        <?supplied-pmid 11751237?>
        <pub-id pub-id-type="pmid">11751237</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
